Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 16101-16150 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT06445335
Prevalence of NAFLD in T2DM Patients
NAActive, not recruiting
385 participants
Started: Mar 1, 2019 · Completed: Nov 1, 2025
4 conditions1 sponsor1 location
NCT03859388
Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection
N/AActive, not recruiting
10 participants
Started: Mar 1, 2019 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06156722
The Combination of Sperm Selection by IMSI and Hyaluronic Acid Binding Assay May Improve ICSI Outcome.
NAActive, not recruiting
189 participants
Started: Mar 1, 2019 · Completed: Feb 1, 2024
1 condition3 sponsors1 location
NCT03184454
Combined Cortical/Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder
NAActive, not recruiting
2 participants
Started: Mar 1, 2019 · Completed: Oct 1, 2025
1 condition1 sponsor2 locations
NCT03632941
A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer
PHASE2Active, not recruiting
8 participants
Started: Mar 1, 2019 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT03863730
Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota
NAActive, not recruiting
56 participants
Started: Mar 1, 2019 · Completed: Feb 28, 2031
4 conditions5 sponsors2 locations
NCT03865823
Evaluation of the Recovery Rate and Postoperative Incontinence of Surgical Fistulas in a Cohort of a Reference Centre
N/AActive, not recruiting
600 participants
Started: Mar 1, 2019 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT03768063
A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study
PHASE3Active, not recruiting
1,000 participants
Started: Feb 28, 2019 · Completed: Jul 5, 2028
1 condition1 sponsor87 locations
NCT03820063
Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study
PHASE2Active, not recruiting
462 participants
Started: Feb 27, 2019 · Completed: May 1, 2032
1 condition3 sponsors52 locations
NCT04416646
Cabozantinib in the Elderly With Metastatic Renal Cell Carcinoma
N/AActive, not recruiting
100 participants
Started: Feb 27, 2019 · Completed: Mar 1, 2024
1 condition1 sponsor1 location
NCT04126772
Multimodal Imaging of MS Reveals the Smoldering Inflammation
N/AActive, not recruiting
40 participants
Started: Feb 27, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03827798
Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa
PHASE2Active, not recruiting
248 participants
Started: Feb 27, 2019 · Completed: Dec 11, 2026
1 condition1 sponsor36 locations
NCT03786081
Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer
PHASE1/PHASE2Active, not recruiting
214 participants
Started: Feb 27, 2019 · Completed: Mar 31, 2026
1 condition6 sponsors71 locations
NCT03862157
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
PHASE1/PHASE2Active, not recruiting
40 participants
Started: Feb 27, 2019 · Completed: Jan 31, 2027
16 conditions2 sponsors1 location
NCT03534934
CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD
NAActive, not recruiting
560 participants
Started: Feb 26, 2019 · Completed: Jun 1, 2025
2 conditions3 sponsors2 locations
NCT03935685
Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ
PHASE2Active, not recruiting
120 participants
Started: Feb 26, 2019 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT03884998
Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma
PHASE1Active, not recruiting
27 participants
Started: Feb 26, 2019 · Completed: Nov 28, 2025
7 conditions2 sponsors3 locations
NCT03756792
Assessing Patient Anxiety During Mohs Micrographic Surgery
NAActive, not recruiting
100 participants
Started: Feb 26, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT03836261
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
PHASE3Active, not recruiting
984 participants
Started: Feb 25, 2019 · Completed: Jan 31, 2027
1 condition2 sponsors170 locations
NCT03856086
Comparing Distress Screening + Consultation With Enhanced Usual Care for Caregivers of Cancer Patients
NAActive, not recruiting
150 participants
Started: Feb 25, 2019 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT04565691
Bacteremia From Periodontal Treatment to Elucidate the Underpinnings of Sepsis
NAActive, not recruiting
100 participants
Started: Feb 25, 2019 · Completed: Dec 31, 2027
4 conditions3 sponsors1 location
NCT03886324
POISE I Pilot Study
NAActive, not recruiting
10 participants
Started: Feb 25, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT02520063
Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer
PHASE1/PHASE2Active, not recruiting
15 participants
Started: Feb 23, 2019 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT04523987
A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.
PHASE1Active, not recruiting
10 participants
Started: Feb 22, 2019 · Completed: Feb 28, 2027
1 condition1 sponsor1 location
NCT03672630
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
PHASE2/PHASE3Active, not recruiting
474 participants
Started: Feb 22, 2019 · Completed: Oct 25, 2025
2 conditions27 sponsors26 locations
NCT03752333
Trial of Pembrolizumab in Cancer of Unknown Primary
PHASE2Active, not recruiting
77 participants
Started: Feb 22, 2019 · Completed: Sep 30, 2024
1 condition2 sponsors1 location
NCT03721341
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors
PHASE3Active, not recruiting
204 participants
Started: Feb 22, 2019 · Completed: Jan 31, 2029
1 condition5 sponsors14 locations
NCT03616028
The CONFORMAL Early Feasibility Study
NAActive, not recruiting
64 participants
Started: Feb 22, 2019 · Completed: Jun 30, 2025
1 condition2 sponsors11 locations
NCT03456336
Management of the PDA Trial
PHASE3Active, not recruiting
836 participants
Started: Feb 22, 2019 · Completed: May 30, 2027
4 conditions2 sponsors19 locations
NCT03821935
Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors
PHASE1Active, not recruiting
364 participants
Started: Feb 21, 2019 · Completed: Jun 30, 2027
1 condition1 sponsor64 locations
NCT03847857
Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)
PHASE3Active, not recruiting
360 participants
Started: Feb 21, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor6 locations
NCT03515993
Follow-up in Gynecological Cancer Survivors
N/AActive, not recruiting
1,100 participants
Started: Feb 21, 2019 · Completed: Apr 30, 2024
1 condition1 sponsor21 locations
NCT03873818
Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain
PHASE2Active, not recruiting
26 participants
Started: Feb 21, 2019 · Completed: Aug 31, 2026
4 conditions2 sponsors1 location
NCT03655002
IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer
PHASE1Active, not recruiting
8 participants
Started: Feb 21, 2019 · Completed: Mar 30, 2026
5 conditions2 sponsors3 locations
NCT03832569
Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors
EARLY_PHASE1Active, not recruiting
17 participants
Started: Feb 20, 2019 · Completed: Feb 28, 2026
2 conditions2 sponsors7 locations
NCT03613246
NVT ALLEGRA TAVI System TF in Failing Calcified Aortic Heart Valves in a Real-world Patient Population
N/AActive, not recruiting
346 participants
Started: Feb 20, 2019 · Completed: Jan 26, 2029
1 condition1 sponsor14 locations
NCT03723551
Study to Assess Safety, Tolerability and Efficacy of Afabicin in The Treatment of Participants With Bone or Joint Infection Due to Staphylococcus
PHASE2Active, not recruiting
111 participants
Started: Feb 20, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor19 locations
NCT06222905
Analysis of Remote Monitoring/Virtual Clinic Data in Adult Patients With Cystic Fibrosis (Project Breathe)
N/AActive, not recruiting
475 participants
Started: Feb 20, 2019 · Completed: Dec 31, 2030
1 condition4 sponsors2 locations
NCT04769921
Full Arch Rehabilitations Through the Contemporary All-on-4 Concept
N/AActive, not recruiting
43 participants
Started: Feb 19, 2019 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT03696654
High Blood Pressure in Paediatric Patients With Sleep Disorder Breathing.
NAActive, not recruiting
286 participants
Started: Feb 19, 2019 · Completed: Jan 1, 2026
2 conditions8 sponsors1 location
NCT03767621
Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR
N/AActive, not recruiting
300 participants
Started: Feb 19, 2019 · Completed: Nov 30, 2026
4 conditions1 sponsor38 locations
NCT03784326
Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma
PHASE2Active, not recruiting
43 participants
Started: Feb 19, 2019 · Completed: Dec 31, 2026
24 conditions2 sponsors1 location
NCT03818087
Elevate! : An Elderly Breast Cancer Cohort Study
N/AActive, not recruiting
253 participants
Started: Feb 19, 2019 · Completed: Nov 1, 2028
1 condition2 sponsors4 locations
NCT03825523
Immediate ART in Subjects with Opportunistic Diseases
NAActive, not recruiting
114 participants
Started: Feb 18, 2019 · Completed: Sep 1, 2025
2 conditions1 sponsor1 location
NCT03425565
A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer
PHASE2Active, not recruiting
48 participants
Started: Feb 18, 2019 · Completed: Sep 30, 2024
3 conditions1 sponsor5 locations
NCT03858244
Idiopathic Scoliosis Progression and Sleep-disordered Breathing in Children
N/AActive, not recruiting
352 participants
Started: Feb 18, 2019 · Completed: Mar 1, 2025
3 conditions5 sponsors1 location
NCT03737461
Efficacy of Intradiscal Injection of BM-MSC in Subjects With Chronic Low Back Pain (LBP) Due to Lumbar Degenerative Disc Disease (DDD) Unresponsive
PHASE2/PHASE3Active, not recruiting
113 participants
Started: Feb 18, 2019 · Completed: Mar 8, 2026
2 conditions17 sponsors9 locations
NCT03673800
Cognitive Control Training in Online Problem Gambling
NAActive, not recruiting
200 participants
Started: Feb 18, 2019 · Completed: Mar 31, 2024
1 condition2 sponsors1 location
NCT03843034
Endometrial Markers in Autoimmune Diseases
N/AActive, not recruiting
22 participants
Started: Feb 18, 2019 · Completed: Dec 31, 2023
3 conditions1 sponsor1 location
NCT03753074
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines
PHASE4Active, not recruiting
780 participants
Started: Feb 18, 2019 · Completed: Dec 31, 2031
1 condition22 sponsors10 locations